ArticlePloS one2025

Retraction: Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.